When and how to treat women with HER2-positive, small (pT1a-b), node-negative breast cancer?
Articolo
Data di Pubblicazione:
2018
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
Breast cancer; Chemotherapy; HER2-positive; Node-negative; Small (pT1a-b); Trastuzumab; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Lymph Nodes; Neoplasm Staging; Prognosis; Receptor, ErbB-2; Hematology; Oncology
Elenco autori:
Gori, Stefania; Turazza, Monica; Modena, Alessandra; Duranti, Simona; Zamboni, Giuseppe; Alongi, Filippo; Carbognin, Giovanni; Massocco, Alberto; Salgarello, Matteo; Inno, Alessandro
Link alla scheda completa:
Pubblicato in: